Expression of GB virus C NS5A protein from genotypes 1, 2, 3 and 5 and a 30 aa NS5A fragment inhibit human immunodeficiency virus type 1 replication in a CD4+ T-lymphocyte cell line

Journal of General Virology

Volumn 88, Issue 12, 2007, Pages 3341-3346

  Chang, Qing ^a   McLinden, James H ^a   Stapleton, Jack T ^a   Sathar, M Aslam ^b   Xiang, Jinhua ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; NONSTRUCTURAL PROTEIN 5A; PHOSPHOPROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENE SEQUENCE; GENETIC CODE; GENETIC DIFFERENCE; GENOTYPE; HEPATITIS G VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA EXTRACTION; VIRUS CHARACTERIZATION; VIRUS INHIBITION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CHEMOKINE CXCL12; DOWN-REGULATION; GB VIRUS C; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; RECEPTORS, CXCR4; SEQUENCE ALIGNMENT; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

FLAVIVIRUS; GB VIRUS C; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 36749064391     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83198-0     Document Type: Article

References (30)

1. Alter, H. J. (1997). G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 37, 569-572.
2. Amella, C. A., Sherry, B., Shepp, D. H. & Schmidtmayerova, H. (2005). Macrophage inflammatory protein 1α inhibits postentry steps of human immunodeficiency virus type 1 infection via suppression of intracellular cyclic AMP. J Virol 79, 5625-5631.
3. Birk, M., Lindback, S. & Lidman, C. (2002). No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS 16, 2482-2485.
4. Bjorkman, P., Flamholc, L., Naucler, A., Molnegren, V., Wallmark, E. & Widell, A. (2004). GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 18, 877-886.
5. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C. & Lusso, P. (1995). Identification of RANTES, MIP-1a, and MIP-1b as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-1815.
6. Copeland, K. F. (2005). Modulation of HIV-1 transcription by, cytokines and chemokines. Mini Rev Med Chem 5, 1093-1101.
7. George, S. L., Varmaz, D. & Stapleton, J. T. (2006). GB virus C replicates in primary T and B lymphocytes. J Infect Dis 193, 451-454.
8. Jung, S., Knauer, O., Donhauser, N., Eichenmuller, M., Heim, M., Fleckenstein, B. & Reil, H. (2005). Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors. AIDS 19, 1267-1272.
9. Jung, S., Eichenmueller, M., Donhauser, N., Neipel, F., Engel, A. M., Hess, G., Fleckenstein, B. & Reil, H. (2007). HIV entry inhibition by the envelope 2 glycoprotein of GB virus C. AIDS 21, 645-647.
10. Leary, T. P., Muerhoff, A. S., Simons, J. N., Pilot-Matias, T. J., Erker, J. C., Chalmers, M. L., Schlauder, G. G., Dawson, G. J., Desai, S. M. & Mushahwar, I. K. (1996). Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 48, 60-67.
11. Lin, Y. L., Mettling, C., Portales, P., Reynes, J., Clot, J. & Corbeau, P. (2002). Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection. Proc Natl Acad Sci U S A 99, 15590-15595.
12. Linnen, J., Wages, J., Zhang-Keck, Z.-Y., Fry, K. E., Krawczynski, K. Z., Alter, H., Koonin, E., Gallagher, M., Alter, M. & other authors (1996). Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271, 505-508.
13. Macdonald, A. & Harris, M. (2004). Hepatitis C virus NS5A: tales of a promiscuous protein. J Gen Virol 85, 2485-2502.
14. Muerhoff, A. S., Tillmann, H. L., Manns, M., Dawson, G. J. & Desai, S. M. (2003). GB virus C genotype determination in GB virus-C/ HIV co-infected individuals. J Med Virol 70, 141-149.
15. Nattermann, J., Nischalke, H. D., Kupfer, B., Rockstroh, J., Hess, L., Sauerbruch, T. & Spengler, U. (2003). Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 17, 1457-1462.
16. Polgreen, P. M., Xiang, J., Chang, Q. & Stapleton, J. T. (2003). GB virus type C/hepatitis G virus: a nonpathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes Infect 5, 1255-1261.
17. Schwarze-Zander, C., Blackard, J. T., Zheng, H., Addo, M. M., Lin, W., Robbins, G. K., Sherman, K. E., Zdunek, D., Hess, G. & other authors (2006). GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis 194, 410-419.
18. Simons, J. N., Leary, T. P., Dawson, G. J., Pilot-Matias, T. J., Muerhoff, A. S., Schlauder, G. G., Desai, S. M. & Mushahwar, I. K (1995). Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1, 564-569.
19. Smith, D. B., Cuceanu, N., Davidson, F., Jarvis, L. M., Mokili, J. L., Hamid, S., Ludlam, C. A. & Simmonds, P. (1997). Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5′ non-coding region. J Gen Virol 78, 1533-1542.
20. Stapleton, J. T. (2003). GB virus type C/hepatitis G virus. Semin Liver Dis 23, 137-148.
21. Stapleton, J. T., Williams, C. F. & Xiang, J. (2004). GB virus C: a beneficial infection? J Clin Microbiol 42, 3915-3919.
22. Van der Bij, A. K., Kloosterboer, N., Prins, M., Boeser-Nunnink, B., Geskus, R. B., Lange, J. M. A., Coutinho, R. A. & Schuitemaker, H. (2005). GB virus C coinfection and HIV-1 disease progression: the Amsterdam cohort study. J Infect Dis 191, 678-685.
23. Williams, C. F., Klinzman, D., Yamashita, T. E., Xiang, J., Polgreen, P. M., Rinaldo, C., Liu, C., Phair, J., Margolick, J. B. & other authors (2004). Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350, 981-990.
24. Xiang, J., Wunschmann, S., Schmidt, W. N., Shao, J. & Stapleton, J. T. (2000). Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 74, 9125-9133.
25. Xiang, J., Wunschmann, S., Diekema, D. J., Klinzman, D., Patrick, K. D., George, S. L. & Stapleton, J. T. (2001). Effect of coinfection with GB virus C (hepatitis G virus) on survival among patients with HIV infection. N Engl J Med 345, 707-714.
26. Xiang, J., George, S. L., Wunschmann, S., Chang, Q., Klinzman, D. & Stapleton, J. T. (2004). Inhibition of HIV- 1 replication by GB virus C infection through increases in RANTES, MIP-1α, MIP-1β, and SDF-1. Lancet 363, 2040-2046.
27. Xiang, J., Martinez-Smith, C., Gale, M., Jr, LaBrecque, D. R., Schmidt, W. N. & Stapleton, J. T. (2005a). GB virus C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF-2α phosphorylation. J Interferon Cytokine Res 25, 261-270.
28. Xiang, J., Sathar, M. A., McLinden, J. H., Klinzman, D., Chang, Q. & Stapleton, J. T. (2005b). South African GB virus C isolates: interactions between genotypes 1 and 5 GBV-C isolates and the human immunodeficiency virus. J Infect Dis 192, 2147-2151.
29. + Jurkat T-cells. Proc Natl Acad Sci U S A 103, 15570-15575.
30. Zhang, W., Chaloner, K., Tillmann, H. L., Williams, C. F. & Stapleton, J. T. (2006). Effect of early and late GBV-C viremia on survival of HIV infected individuals: a meta-analysis. HIV Med 7, 173-180.